Canadian Stocks Reach Six-Month Highs On Covid-19 Vaccine News

Canadian stocks rose the most in six months on Monday after pharmaceutical company Pfizer Inc. (NYSE:PFE) announced that its Covid-19 vaccine prevented more than 90% of infections in a large-scale clinical trial.

The S&P/TSX Composite Index closed 1.2% higher in Toronto on Monday and was up as much as 2.7% in intra-day trading. The index closed Monday session at its highest level since October 15.

The rally was fueled by investors flooding into cyclical stocks, including energy, which as a group climbed almost 10%. Suncor Energy (TSX:SU) and Canadian Natural Resources (TSX:CNQ), the largest Canadian oil producers, rose more than 20% each on Monday.

Real estate and financial stocks, two of the worst-performing sectors this year, also had a big day, with each rising more than 4%.

Some of the positive momentum was blunted by a selloff in technology stocks such as Shopify, which have benefited from stay-at-home orders during the pandemic and gold miners. The loonie rose 0.3% to $1.3010 per U.S. dollar.

Air Canada (TSX:AC) soared 29% despite missing operating revenue estimates for the third quarter as the prospect for a vaccine improved sentiment toward travel. The airline said it expects flight capacity in the fourth quarter will be 75% lower than in the same quarter last year.

The Government of Canada said Sunday it will begin discussions on providing financial support to airlines, airports and the aerospace sector.

Related Stories